Robopac Partners with Pfizer

It’s official, the COVID-19 vaccine produced by pharmaceutical giant Pfizer has been approved by the FDA (the US’s Food and Drug Administration) and will be rolled out throughout the country to fight the pandemic. Robopac will be guaranteeing the vaccine’s packaging and transport safety following its contribution to the development of ad hoc solutions for the packaging of pharmaceutical products made by the American giant.

A significant achievement for everyone, in which Robopac, once again, has played a leading role in an industrial venture with great humanitarian importance. The partnership between Robopac and Pfizer is based on a shared philosophy that focuses on collective interest from a global perspective, with a view to providing high-performing products that are human-centred and environmentally conscious.

In line with this approach, Ecoplat Plus is the solution adopted by Pfizer for packaging the vaccine doses due to be distributed in the USA. A wrapping turntable featuring state-of-the-art technology, it uses stretch film that guarantees advanced performance including maximum protection of the goods due to its reliability, strength, and ease of use. Not only that, the Ecoplat Plus technology also keeps film consumption down while ensuring product safety, which means a lower impact of the raw material used.

People and the environment are intrinsically linked and Robopac strivers to protect this relationship through continuous investments in innovation and technology. Demonstrating this, four TechLabs set up around the world offer a unique way of conducting research, concentrating above all on reducing the impact of plastic, and have delivered results including 60% less consumption and full recyclability of materials.

Robopac is committed to demonstrating its belief in its role as One Global Company that offers high-performance packaging solutions throughout the world. Its particular focus on the end-of-line equipment is backed by sensitivity to circular economy issues, resulting in a combination of technology, innovation, and sustainability.

The partnership between Robopac and Pfizer is based on a shared philosophy that focuses on collective interest from a global perspective.

At the same time, a widespread presence on international markets allows Robopac to fuel its untiring research and development activities following a tailor-made approach that responds to the most specific needs of each market and each customer. Responsibility and passion are the watchwords at Robopac, accompanied by an ever-growing focus on the environment as a core issue for the company.

With this in mind, Robopac is proud, once again, to be part of a process focusing on the wellbeing of people and to see its technology as part of the fight against Covid-19 and its devastating effects worldwide.